Chinook therapeutics revenue
WebFeb 27, 2024 · The higher revenue amounts in 2024 were primarily due to $41.2 million non-cash revenue recognized under Chinook’s license agreement with SanReno Therapeutics and a $10.0 million milestone ... WebApr 14, 2024 · The firm had revenue of $5.10 million during the quarter, compared to analyst estimates of $0.10 million. Chinook Therapeutics’s revenue was down 90.0% on a year-over-year basis. As a group, equities analysts forecast that Chinook Therapeutics will post -3.19 earnings per share for the current fiscal year. Insider Activity at Chinook …
Chinook therapeutics revenue
Did you know?
WebFeb 27, 2024 · chinook therapeutics - cash, cash equivalents and marketable securities totaled $385.3 million as of dec 31, 2024, versus $355.1 million as of dec 31, 2024 QTRLY REVENUE WAS $0.5 MILLION Q4 EARNINGS PER SHARE VIEW $-0.79, REVENUE VIEW $100000.00 — REFINITIV IBES DATA WebApr 9, 2024 · The firm's quarterly revenue was down 90.0% on a year-over-year basis. Analysts predict that Chinook Therapeutics will post -3.19 EPS for the current year. Insider Transactions at Chinook Therapeutics. In related news, COO Tom Frohlich sold 4,566 shares of Chinook Therapeutics stock in a transaction on Tuesday, January 31st. The …
WebSep 30, 2024 · The increase was primarily due to revenue recognized under Chinook’s license agreement with SanReno Therapeutics and collaboration agreement with Lilly. … WebChinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. Changing the Course of Kidney Care™ Read More
WebFeb 24, 2024 · Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. The company applies its proprietary discovery platform, which leverages single-cell RNA sequencing, human-derived organoids, and new translational models, to discover and develop therapeutics with novel mechanisms of … WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical …
WebChinook Therapeutics revenue is $54 M. How many employees does Chinook Therapeutics have? Chinook Therapeutics has 138 employees. Where is Chinook Therapeutics headquarters located? Chinook Therapeutics headquarters are located in 400 Fairview Avenue North Ste 900, Seattle, Washington, 98109, United States .
WebNov 10, 2024 · Chinook Therapeutics (KDNY) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.68 per share a year ago. circus clown skitsWebFeb 27, 2024 · The higher revenue amounts in 2024 were primarily due to $41.2 million non-cash revenue recognized under Chinook’s license agreement with SanReno … diamond lamb and rice puppyWebMay 12, 2024 · Revenue – Revenue for the quarter ended March 31, 2024 was $2.7 million compared to $0.4 million for the same period in 2024. The increase was primarily due to revenue recognized under Chinook ... diamond lamb and rice dog food ingredientsWebFeb 27, 2024 · Chinook Therapeutics (KDNY) came out with a quarterly loss of $0.90 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compare... circus clown song for kidsWebDec 31, 2024 · Revenue – Total revenue increased by $50.4 million and $50.8 million for the quarter and year ended December 31, 2024, respectively, compared to the same periods in 2024. ... CHINOOK THERAPEUTICS, INC. Consolidated Statements of … circus clowns cartoonsWebApr 9, 2024 · Chinook Therapeutics Trading Down 0.8 %. Shares of KDNY opened at $22.12 on Friday. The firm’s 50-day moving average is $23.02 and its two-hundred day moving average is $22.82. diamond lamp shadesWebFeb 24, 2024 · Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. The company applies its proprietary discovery platform, … circus clown theme song